載入...
EXTH-14. REPURPOSING OF APPROVED DRUGS FOR THE TREATMENT OF GLIOMA STEM CELLS
Glioblastoma (GBM) is the most common and malignant primary brain tumor. Glioma stem cells (GSCs), a subpopulation of GBM cells with stem cell properties, are responsible for the tumor initiation and recurrence, and therapeutic resistance. To develop novel therapeutic agents for sphere-forming patie...
Na minha lista:
| 發表在: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217099/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.363 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|